SUBSCRIBE
SUBSCRIBE

Elutia

NEWS
Dan Kitwood/Getty Images
FDA
Excessive Impurities Cause Recall of Pfizer’s Anti-Smoking Drug
Pfizer has voluntarily recalled two lots of Chantix 0.5 mg tablets, two lots of Chantix 1 mg tablets, and eight lots of a Chantix kit consisting of 0.5mg/1 mg tablets.
July 20, 2021
 · 
2 min read
 · 
Brandon May
Business
Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO
June 15, 2017
 · 
1 min read
IN THE PRESS
Press Releases
Elutia to Present at Sidoti’s Small-Cap Virtual Investor Conference March 18-19
March 17, 2026
 · 
2 min read
Press Releases
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - March 13, 2026
March 13, 2026
 · 
1 min read
Press Releases
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process
March 12, 2026
 · 
16 min read
Press Releases
Elutia Regains Compliance with Nasdaq Listing Requirements
March 4, 2026
 · 
2 min read
Press Releases
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market
March 2, 2026
 · 
7 min read
Press Releases
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026
February 26, 2026
 · 
1 min read
Press Releases
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™
February 18, 2026
 · 
3 min read
Press Releases
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones
January 12, 2026
 · 
7 min read
Press Releases
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery
January 9, 2026
 · 
5 min read
Press Releases
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
November 6, 2025
 · 
15 min read
Load More
JOBS